Chemomab Therapeutics (CMMB) Net Cash Flow (QoQ) (2018 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 111.40% |
| Sep 30, 2023 | 88.18% |
| Jun 30, 2023 | -243.33% |
| Mar 31, 2023 | 160.84% |
| Dec 31, 2022 | 223.78% |
| Sep 30, 2022 | 121.71% |
| Jun 30, 2022 | -197.37% |
| Mar 31, 2022 | 94.11% |
| Dec 31, 2021 | -194.77% |
| Sep 30, 2021 | 40.13% |
| Jun 30, 2021 | -127.49% |
| Mar 31, 2021 | 4,773.77% |
| Dec 31, 2020 | -177.16% |
| Sep 30, 2020 | -116.15% |
| Jun 30, 2020 | 256.22% |
| Mar 31, 2020 | 74.87% |
| Dec 31, 2019 | -50.53% |
| Sep 30, 2019 | 26.65% |
| Jun 30, 2019 | -120.83% |
| Mar 31, 2019 | 702.00% |
| Dec 31, 2018 | 52.00% |
| Sep 30, 2018 | -145.01% |
| Jun 30, 2018 | 2,523.56% |
| Mar 31, 2018 | 58.68% |